Tenggara, M. K., Oh, S.-H., Yang, C., Nariya, H. K., Metz, A. M., Upadhyay, A. A., Gudipati, D. R., Guo, L., McGhee, E. G., Gill, K., Viox, E. G., Mason, R. D., Doria-Rose, N. A., Foulds, K. E., Mascola, J. R., Du, Y., Fu, H., Altman, J. D., Yan, Q., … Kong, R. (2024). Frequency-potency analysis of IgG+ memory B cells delineates neutralizing antibody responses at single-cell resolution. Cell Reports, 43(3), 113948. https://doi.org/10.1016/j.celrep.2024.113948

Singh, Y., Castillo-Mancilla, J., Madimabe, R., Jennings, L., Ferraris, C. M., Robbins, R. N., Anderson, P. L., Remien, R. H., & Orrell, C. (2023). Tenofovir diphosphate in dried blood spots and HIV-1 resistance in South Africa. AIDS Research and Therapy, 20(1). https://doi.org/10.1186/s12981-023-00552-w

Benner, S. E., Zhu, X., Hussain, S., Florman, S., Eby, Y., Fernandez, R. E., Ostrander, D., Rana, M., Ottmann, S., Hand, J., Price, J. C., Pereira, M. R., Wojciechowski, D., Simkins, J., Stosor, V., Mehta, S. A., Aslam, S., Malinis, M., Haidar, G., … Tobian, A. A. R. (2023). HIV-Positive Liver Transplant Does not Alter the Latent Viral Reservoir in Recipients With Antiretroviral Therapy-Suppressed HIV. The Journal of Infectious Diseases, 228(9), 1274–1279. https://doi.org/10.1093/infdis/jiad241

Wang, S., Matassoli, F., Zhang, B., Liu, T., Shen, C.-H., Bylund, T., Johnston, T., Henry, A. R., Teng, I.-T., Tripathi, P., Becker, J. E., Changela, A., Chaudhary, R., Cheng, C., Gaudinski, M., Gorman, J., Harris, D. R., Lee, M., Morano, N. C., … Kwong, P. D. (2023). HIV-1 neutralizing antibodies elicited in humans by a prefusion-stabilized envelope trimer form a reproducible class targeting fusion peptide. Cell Reports, 42(7), 112755. https://doi.org/10.1016/j.celrep.2023.112755

Fritschi, C. J., Anang, S., Gong, Z., Mohammadi, M., Richard, J., Bourassa, C., Severino, K. T., Richter, H., Yang, D., Chen, H.-C., Chiu, T.-J., Seaman, M. S., Madani, N., Abrams, C., Finzi, A., Hendrickson, W. A., Sodroski, J. G., & Smith, A. B. (2023). Indoline CD4-mimetic compounds mediate potent and broad HIV-1 inhibition and sensitization to antibody-dependent cellular cytotoxicity. Proceedings of the National Academy of Sciences, 120(13). https://doi.org/10.1073/pnas.2222073120

Rosenberg, N. E., Shook-Sa, B. E., Liu, M., Stranix-Chibanda, L., Yotebieng, M., Sam-Agudu, N. A., Hudgens, M. G., Phiri, S. J., Mutale, W., Bekker, L.-G., Moyo, S., Zuma, K., Charurat, M. E., Justman, J., & Chi, B. H. (2023). Adult HIV-1 incidence across 15 high-burden countries in sub-Saharan Africa from 2015 to 2019: a pooled analysis of nationally representative data. The Lancet HIV, 10(3), e175–e185. https://doi.org/10.1016/s2352-3018(22)00328-9

Karim, Q. A., Archary, D., Barré-Sinoussi, F., Broliden, K., Cabrera, C., Chiodi, F., Fidler, S. J., Gengiah, T. N., Herrera, C., Kharsany, A. B. M., Liebenberg, L. J. P., Mahomed, S., Menu, E., Moog, C., Scarlatti, G., Seddiki, N., Sivro, A., & Cavarelli, M. (2022). Women for science and science for women: Gaps, challenges and opportunities towards optimizing pre-exposure prophylaxis for HIV-1 prevention. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.1055042

Ebonwu, J., Lassaunière, R., Paximadis, M., Strehlau, R., Gray, G. E., Kuhn, L., & Tiemessen, C. T. (2022). FCGR3A gene duplication, FcγRIIb-232TT and FcγRIIIb-HNA1a associate with an increased risk of vertical acquisition of HIV-1. PLOS ONE, 17(9), e0273933. https://doi.org/10.1371/journal.pone.0273933

Delany-Moretlwe, S., Hughes, J. P., Bock, P., Ouma, S. G., Hunidzarira, P., Kalonji, D., Kayange, N., Makhema, J., Mandima, P., Mathew, C., Spooner, E., Mpendo, J., Mukwekwerere, P., Mgodi, N., Ntege, P. N., Nair, G., Nakabiito, C., Nuwagaba-Biribonwoha, H., Panchia, R., … Gaffoor, Z. (2022). Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial. The Lancet, 399(10337), 1779–1789. https://doi.org/10.1016/s0140-6736(22)00538-4